[Federal Register Volume 61, Number 114 (Wednesday, June 12, 1996)]
[Notices]
[Page 29769]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-14795]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Inter Company Collaboration for Aids Drug 
Development

    Notice is hereby given that, on May 24, 1996, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. Sec. 4301 et seq. (``the Act''), Inter Company Collaboration 
for Aids Drug Development (The Collaboration) filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission reflecting changes in membership. The notifications 
were filed for the purpose of extending the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances. The changes are that Triangle Pharmaceuticals, Inc., of 
Durham, North Carolina and Agouron Pharmaceuticals, Inc., of La Jolla, 
California, have become members of the Collaboration.
    No other changes have been made in either the membership or planned 
activities of the Collaboration. Membership in the Collaboration 
remains open, and the Collaboration intends to file additional written 
notifications disclosing all changes in membership.
    On My 27, 1993, the Collaboration filed its original notification 
pursuant to Section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to Section 6(b) of 
the Act on July 6, 1993 (58 FR 36223).
    The last notification was filed with the Department on May 18, 
1995. A notice was published in the Federal Register on February 23, 
1996 (61 FR 7019).
Constance K. Robinson,
Director of Operations Antitrust Division.
[FR Doc. 96-14795 Filed 6-11-96; 8:45 am]
BILLING CODE 4410-01-M